Technical analysis of Telix Pharmaceuticals Limited (TLX): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Telix Pharmaceuticals Limited, a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals. The company operates through three segments: Precision Medicine, Therapeutics, and Manufacturing Solutions. Its lead therapeutic product candidate is TLX591, a lutetium-labeled radio antibody-drug conjugate (rADC), which is in a Phase 3 clinical trial in patients with advanced prostate cancer.
Price Performance
| 1 month | -14.22% |
| 3 months | -13.15% |
| Year-to-date | +20.83% |
| 1 year | -12.90% |
52-Week Range
| 52-week High | $13.11 |
| 52-week Low | $6.28 |
| Avg Volume (90d) | 271K |
Technical Indicators
| SMA 50 | $11.01 |
| SMA 200 | $9.91 |
| Beta | 0.61 |
| 30-day Volatility (annualised) | 52.5% |
| Price vs SMA 50 | -17.8% |
| Price vs SMA 200 | -8.7% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-12 | $7.49 | |
| 2026-01 | $7.28 | -2.8% |
| 2026-02 | $7.25 | -0.4% |
| 2026-03 | $9.57 | +32.0% |
| 2026-04 | $11.00 | +14.9% |
| 2026-05 | $9.43 | -14.3% |
| 2026-06 | $11.53 | +22.3% |
| 2026-07 | $9.89 | -14.2% |
| 2026-08 | $11.09 | +12.1% |
| 2026-09 | $10.97 | -1.1% |
| 2026-10 | $9.10 | -17.0% |
| 2026-11 | $9.05 | -0.5% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2027-02-19 | $-0.07 | $494M |
| 2026-08-19 | $0.04 | $480M |
| 2026-02-19 | $0.03 | $418M |
| 2025-08-20 | $0.13 | $390M |
| 2025-02-20 | $0.09 | $135M |
| 2024-08-22 | $0.09 | $238M |
| 2024-05-17 | | $113M |
Price
| Price | $9.05 (closing price, November 2, 2026) |
| Market Cap | $3.1B |
| Exchange | NASDAQ |
| Country | AU |
Valuation Ratios
| P/E Ratio | 95.01 |
| Price / Book | 6.32 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 1.19 |
| Current Ratio | 2.01 |
| Piotroski F-Score | 2 |
| Altman Z-Score | 2.62 |